TRP Health Policy’s mission is to help people be healthy, and we understand that is the essence of your mission too. To get there in this rapidly evolving policy space, you need both political heft and substantive depth. That’s why we deliver insightful, actionable analysis and sophisticated, informed advocacy to help you achieve your goals.
The result: a government affairs partner that actually understands this stuff, empowering clients to get their answers first, understand them better, and act on them with unparalleled confidence and precision.
This is where we put the *know* in TRP Health Policy, and in you. Nowhere else will you find every reg, every hearing, every grant, every ACA section, every topic, every policy development broken down for you, with careful analysis and insight you can act on - now.
Our promise: you will understand every policy impacting your specific goals and be fully prepared to respond. We don’t sit back waiting for your call – keeping you one step ahead is our job. Our personalized, concierge service will give you the strongest platform for building your policy success.
Don’t react to policy, redefine it. With seasoned veterans of CMS and Capitol Hill’s healthcare committees, let us hone and amplify your message, ensuring it resonates with policymakers. In healthcare, it’s the right care. In policy, it’s the right message – at the right time, delivered to the right people. That’s where we excel.
The Centers for Medicare and Medicaid Services (CMS) has released a highly anticipated proposed rule (fact sheet) addressing Contract Year (CY) 2019 Policy and Technical Changes for Medicare Advantage and Part D plans. CMS includes an assortment of proposals affecting MA and Part D plans in CY 2019. While subregulatory changes and rate updates are effectuated through the annual Call Letter... More (Zatorski, 11/16/17) #Benefit Design, #Biosimilars, #Generic Drugs, #Medicare Advantage, #Medicare Part D, #Opioids, #Pharmaceuticals, #Pharmacy, #Pharmacy Benefit Managers (PBMs)
The House of Representatives passed H.R. 1 – the Tax Cuts and Jobs Act (TCJA) by a vote of 227 to 205, marking a significant step forward in the Republican effort to overhaul the tax code. As expected, the bill was passed on the strength of the Republican majority, with 13 Republicans joining all voting Democrats in opposing the measure. The... More (Zatroski, 11/16/17) #Pharmaceuticals